Hims vs Spry
Hims and Spry both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
If you are choosing between Hims and Spry, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hims leads our six-part score, 6.8 to 6.0. One of the two has an FDA warning letter on record, covered below.
Hims vs Spry price
Hims and Spry start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide costs the same at both, $299 a month.
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Hims prices compounded injections and brand-name pens, while Spry prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
Hims lists 50 states, and Spry does not publish where it ships.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Spry
What each price covers
Hims' price also covers the medication itself, which Spry does not claim.
Hims is silent on shipping and lab work.
Spry does not say what its price includes.
That matters most for the drug: unless Spry confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Spry
Inclusions not disclosed.
Where each one scores higher
Overall, Hims scores 6.8 and Spry 6.0 out of 10.
Hims is stronger on trust & safety (7.0 vs 3.5) and accessibility (10.0 vs 5.0).
Spry is stronger on support (5.0 vs 3.0).
Value, effectiveness and user experience are within half a point.
Hims
6.8/10
Spry
6.0/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Spry has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Spry |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | 2 features | ✓5 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Spry
Semaglutide compounded is $199/mo here and tirzepatide $299/mo. Three longevity peptides sit alongside, BPC-157, NAD+ and sermorelin, at $249-$299/mo. Spry names three co-founders, holds LegitScript certification, ties nobody to a contract, and has a nurse practitioner look at intake inside 24 hours. One caution: an 'FDA Approved' badge appears on the site, and compounded GLP-1s are not finished products carrying FDA approval.
Read our full Spry review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Spry
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- We found no FDA warning letters issued to Spry
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hims wins this one, 6.8 to 6.0, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. Spry fits better if seeing what it charges before you answer any medical questions is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose Spry if…
You want seeing what it charges before you answer any medical questions and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Hims vs Spry: FAQ
Close alternatives to Hims and Spry
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Spry vs Hers
- Spry vs Curex
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.